Irina V. Ledenyova

Irina V. Ledenyova

Auto-generated profile, based on publicly available information

Irina V. Ledenyova

Voronezh State University, Voronezh, Russia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2020 in Molecules
Verified
Journal Article
Open access
PDF file
NNNadezhda Novichikhina
Nadezhda Novichikhina
IIIvan Ilin
Ivan Ilin
ATAnna Tashchilova
Anna Tashchilova
ASAlexey Sulimov
Alexey Sulimov
DKDanil Kutov
Danil Kutov
VSVladimir Sulimov
Vladimir Sulimov
Coagulation factor Xa and factor XIa are proven to be convenient and crucial protein targets for treatment for thrombotic disorders and thereby their inhibitors can serve as effective anticoagulant drugs. In the present work, we focused on the structure–activity relationships of derivatives of pyrrolo[3,2,1-ij]quinolin-2(1H)-one and an evaluation of their activity against factor Xa and factor XIa. For this, docking-guided synthesis of nine compounds based on pyrrolo[3,2,1-ij]quinolin-2(1H)-one was carried out. For the synthesis of new hybrid hydropyrrolo[3,2,1-ij]quinolin-2(1H)-one derivatives, we used convenient structural modification of both the tetrahydro- and dihydroquinoline moiety by varying the substituents at the C6,8,9 positions. In vitro testing revealed that four derivatives were able to inhibit both coagulation factors and three compounds were selective factor XIa inhibitors. An IC50 value of 3.68 μM for was found for the best factor Xa inhibitor and 2 μM for the best factor XIa inhibitor.

20 November 2014 in Chemistry of Heterocyclic Compounds
Verified
Journal Article
Closed access
PDF file
ILI. V. Ledenyova
I. V. Ledenyova
VDV. V. Didenko
V. V. Didenko
KSKhidmet Shikhaliev
Khidmet Shikhaliev

28 March 2020 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Open access
PDF file
NPNadezhda Podoplelova
Nadezhda Podoplelova
VSVladimir Sulimov
Vladimir Sulimov
ИИИ. С. Ильин
И. С. Ильин
ATA. S. Tashilova
A. S. Tashilova
MPMikhail A. Panteleev
Mikhail A. Panteleev
KSKhidmet Shikhaliev
Khidmet Shikhaliev
Disorders in the blood coagulation system are the leading cause of death and disability in the modern world. So the search for new drugs that can prevent pathological thrombosis, while not affecting normal hemostasis, becomes more relevant than ever. Recent studies has been a revolution in the understanding of the principles of work and the regulation of blood coagulation. In addition, new, more effective approaches to drug development have now appeared. For example computer simulation methods that can significantly reduce the time and resources spent on the search for new candidate molecules. In the review, the blood clotting system, the molekular mechanisms of thrombosis, the role of blood coagulation factors Xa and XIa, and the urgency of developing new inhibitors of these targets are shown, and the most interesting inhibitors of factors Xa and XIa are presented.

30 May 2013 in Journal of Heterocyclic Chemistry
Verified
Journal Article
Closed access
PDF file
ILIrina V. Ledenyova
Irina V. Ledenyova
VDVitaly V. Didenko
Vitaly V. Didenko
ASAlexander S. Shestakov
Alexander S. Shestakov
KSKhidmet Shikhaliev
Khidmet Shikhaliev

1 January 2018 in Russian Journal of General Chemistry
Verified
Journal Article
Closed access
PDF file
ILI. V. Ledenyova
I. V. Ledenyova
AFA. V. Falaleev
A. V. Falaleev
KSKh. S. Shikhaliev
Kh. S. Shikhaliev
ERE. A. Ryzhkova
E. A. Ryzhkova
Fedor ZubkovFedor Zubkov
Fedor Zubkov
The reaction of ethyl 4-(chloromethyl)pyrazolo[5,1- c][1,2,4]triazine-3-carboxylates with thiourea in dimethylformamide involves ANRORC rearrangement (Addition of the Nucleophile, Ring Opening, and...

1 August 2015 in Chemistry of Heterocyclic Compounds
Verified
Journal Article
Closed access
PDF file
ILIrina V. Ledenyova
Irina V. Ledenyova
AGAlena A. Gracheva
Alena A. Gracheva
KSKhidmet Shikhaliev
Khidmet Shikhaliev